Deep Genomics: Home
Có thể bạn quan tâm
- Company
- AI Platform
- News
- Blog
- Careers
- Contact
AI-Powered Discovery
The future of drug development will rely on artificial intelligence, because biology is too complex for humans to understand
RNA as a therapeutic modality has arrived on a global scale with new medicines approved for rare disease and as vaccines. This is only the beginning. Everyone will face a genetic condition in their lifetime. And, because RNA therapies can be programmed to precisely target genetic causes, we can conceive of addressing most genetic conditions. Finding therapies requires mining RNA biology data. But, this data is vast, complex and overwhelming, making standard approaches to drug discovery too slow and costly.
Deep Genomics has the solution: Our AI Platform untangles the complexity in RNA biology, identifies novel targets, and evaluates thousands of possibilities to identify the best therapeutic candidates.
We seek to program therapies for any gene and any genetic condition.
Learn MoreAI Drives Unprecedented Number of Valuable Medicines by Combining Prediction and Scale
Our proprietary AI Platform is designed for data-driven prediction, positive feedback loops, and exponential growth.
In 2018, our proprietary AI Platform unlocked our first targets in which RNA splicing was the defect and the mechanism for correction. In 2023 we released the first Foundation Model for RNA Biology, BigRNA.
We are currently developing BigRNA+, which will expand the number of mechanisms and genetic variants we can pursue. This includes expanding into more complex genetic diseases and discovering new biology. As genetic targets are less understood in complex genetic disease, the AI Platform will play an even greater role in identifying novel targets, as well as therapies, to modulate disease.
Learn MoreJoin Us
We are looking for individuals who are inspired to join us in building a new kind of world-class genetic medicine company.
Learn MoreFind Us
Corporate Headquarters: 480 University Avenue, Suite 1300 Toronto, Ontario, Canada, M5G 1V2 Boston Office: 1 Canal Park, Suite 100 Cambridge, MA 02141, USAFollow Us
Contact Us
For PR enquiries: [email protected] © 2025 DEEP GENOMICS. ALL RIGHTS RESERVED. PRIVACY POLICYTừ khóa » Thuốc Rna
-
Understanding MRNA COVID-19 Vaccines - CDC
-
Một Mũi Tiêm RNA Có Giá Hơn 60 Triệu, Giúp Hạ Mỡ Máu, Phòng Ngừa ...
-
Tìm Hiểu Công Nghệ Nano Trong Sản Xuất Vắc Xin MRNA COVID-19
-
Definition Of MRNA - NCI Dictionary Of Cancer Terms
-
Definition Of CAR T-cell Therapy - NCI Dictionary Of Cancer Terms
-
[PDF] Chỉnh Lại Những điều Lầm Tưởng Về Thuốc Chủng Ngừa COVID-19
-
Phát Triển Thuốc Dựa Trên RNA Có Thể Ngăn Ngừa COVID-19 Kéo Dài
-
Rifamycins - Bệnh Truyền Nhiễm - Phiên Bản Dành Cho Chuyên Gia
-
Thuốc Kháng Virus Molnupiravir Có Gây Yếu Sinh Lý? - Tin Liên Quan
-
RNA Tiền Gen Của Virus Viêm Gan B (HBV PgRNA) | Medlatec
-
[PDF] RNA Drugs - VNU Journal Of Science
-
Bản Mẫu:Thuốc Kháng Virus RNA – Wikipedia Tiếng Việt
-
AstraZeneca Hướng Tới Sản Xuất Thuốc Dựa Trên Công Nghệ RNA Tự ...